For informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Metabolism, recovery and emerging research
A deep dive into peptide reconstitution, shaking, temperature and storage, separating original COA results from claims about purity, potency and sterility.
Read articleExplore how eloralintide differs from GLP-1 medicines, its human trial results, September 2026 combination data and the questions phase 3 must answer.
Read articleWhat FLOW's kidney results mean for people with type 2 diabetes, how to read the risk figures, and where the evidence remains uncertain.
Read articleUnderstand peptide half-life, how repeated doses build up, when levels reach steady state, and why clearance differs from the duration of a drug's effects.
Read articleTRIUMPH-1 and TRIUMPH-2 now have published phase 3 papers. Learn how populations, estimands and follow-up change the meaning of each retatrutide headline.
Read articleSURMOUNT-5 directly compared tirzepatide and semaglutide for weight loss. Learn what the 72-week averages mean and which treatment questions remain unanswered.
Read articleSURMOUNT-OSA showed fewer breathing events with tirzepatide. Learn how AHI, oxygen burden, symptoms and PAP reassessment fit together.
Read articleSURMOUNT-4 clarifies what happens after initial tirzepatide weight loss—and why ongoing treatment and an individualized maintenance plan are separate questions.
Read articleWhat SUMMIT found about worsening heart failure and daily function, and why its findings apply to a specific group with obesity and HFpEF.
Read articleThe evidence behind tirzepatide's oral-contraception precaution, its four-week windows and the separate issue of vomiting or diarrhea.
Read articleTB-500's uncertain recovery evidence does not soften its anti-doping status. Athletes need separate answers about health, eligibility, and product identity.
Read articleForzinity's Barth syndrome approval is meaningful, but it does not establish healthy-aging or lifespan benefits. Here is what the human and animal findings show.
Read article1–12 of 323 articles
